CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
This Quarter Return
+18.02%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$1.06B
AUM Growth
+$1.06B
(-1.1%)
Cap. Flow
-$150M
Cap. Flow
% of AUM
-14.08%
Top 10 Holdings %
Top 10 Hldgs %
37.54%
Holding
501
New
15
Increased
263
Reduced
171
Closed
24
Top Buys
| 1 |
SPDR Gold Trust
GLD
|
$6.59M |
| 2 |
iShares Gold Trust Micro
IAUM
|
$4.62M |
| 3 |
Intuit
INTU
|
$3.73M |
| 4 |
SPDR Gold MiniShares Trust
GLDM
|
$3.6M |
| 5 |
T-Mobile US
TMUS
|
$2.35M |
Top Sells
| 1 |
Apple
AAPL
|
$17.4M |
| 2 |
NVIDIA
NVDA
|
$12.2M |
| 3 |
Microsoft
MSFT
|
$11.5M |
| 4 |
Amazon
AMZN
|
$8.86M |
| 5 |
Broadcom
AVGO
|
$8.43M |
Sector Composition
| 1 | Technology | 38.15% |
| 2 | Healthcare | 22.68% |
| 3 | Communication Services | 12.64% |
| 4 | Consumer Discretionary | 11.62% |
| 5 | Consumer Staples | 3.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
iShares Gold Trust
IAU
$50.6B
| $2.87M | 0.27% |
46,000
+12,000
| +35% | +$748K |
|
77
Automatic Data Processing
ADP
$123B
| $2.86M | 0.27% |
9,216
-833
| -8% | -$258K |
|
78
Boston Scientific
BSX
$156B
| $2.85M | 0.27% |
26,576
+8,139
| +44% | +$874K |
|
79
Revolution Medicines
RVMD
$7.1B
| $2.85M | 0.27% |
77,411
-12,551
| -14% | -$462K |
|
80
Autodesk
ADSK
$67.3B
| $2.84M | 0.27% |
9,159
-2,051
| -18% | -$635K |
|
81
British American Tobacco
BTI
$124B
| $2.82M | 0.27% |
59,073
+45,069
| +322% | +$2.15M |
|
82
JPMorgan Chase
JPM
$829B
| $2.77M | 0.26% |
9,543
-6,105
| -39% | -$1.77M |
|
83
Abbott
ABT
$231B
| $2.73M | 0.26% |
20,045
-3,721
| -16% | -$506K |
|
84
monday.com
MNDY
$9.95B
| $2.67M | 0.25% |
8,500
-9,200
| -52% | -$2.89M |
|
85
Incyte
INCY
$16.5B
| $2.65M | 0.25% |
38,878
+60
| +0.2% | +$4.09K |
|
86
United Therapeutics
UTHR
$13.8B
| $2.6M | 0.24% |
9,059
+50
| +0.6% | +$14.4K |
|
87
Neurocrine Biosciences
NBIX
$13.8B
| $2.5M | 0.24% |
19,877
-122
| -0.6% | -$15.3K |
|
88
Johnson & Johnson
JNJ
$427B
| $2.49M | 0.23% |
16,283
-2,036
| -11% | -$311K |
|
89
Exelixis
EXEL
$10.1B
| $2.41M | 0.23% |
54,772
-1,367
| -2% | -$60.3K |
|
90
ASML
ASML
$292B
| $2.39M | 0.23% |
2,985
-246
| -8% | -$197K |
|
91
Starbucks
SBUX
$100B
| $2.37M | 0.22% |
25,898
-2,254
| -8% | -$207K |
|
92
Strategy Inc Common Stock Class A
MSTR
$94.8B
| $2.33M | 0.22% |
5,762
-109
| -2% | -$44.1K |
|
93
Constellation Energy
CEG
$96.2B
| $2.3M | 0.22% |
7,116
-611
| -8% | -$197K |
|
94
Merck
MRK
$210B
| $2.28M | 0.21% |
28,588
-27,978
| -49% | -$2.23M |
|
95
Berkshire Hathaway Class B
BRK.B
$1.09T
| $2.22M | 0.21% |
4,573
-2,824
| -38% | -$1.37M |
|
96
Intel
INTC
$107B
| $2.22M | 0.21% |
99,038
-7,909
| -7% | -$177K |
|
97
iShares Silver Trust
SLV
$19.6B
| $2.18M | 0.21% |
66,400
+55,000
| +482% | +$1.8M |
|
98
ProShares Ultra Gold
UGL
$575M
| $2.18M | 0.2% |
62,800
+35,100
| +127% | +$1.22M |
|
|
VRNA
99
Verona Pharma
VRNA
$9.16B
| $2.17M | 0.2% |
22,961
-6
| -0% | -$567 |
|
|
TEM
100
Tempus AI, Inc. Class A Common Stock
TEM
$13.2B
| $2.14M | 0.2% |
33,757
+226
| +0.7% | +$14.4K |
|